流通市值:245.32亿 | 总市值:247.17亿 | ||
流通股本:51.54亿 | 总股本:51.93亿 |
报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
一、经营活动产生的现金流量: | ||||
销售商品、提供劳务收到的现金 | 553,535,399,494.46 | 367,439,229,824.47 | 166,381,802,987.22 | 680,267,338,813.68 |
收到的税费返还 | 891,158,240.84 | 593,827,213.19 | 274,694,125.97 | 1,340,438,995.64 |
收到其他与经营活动有关的现金 | 8,840,909,136.85 | 5,028,346,340.06 | 4,139,968,750.89 | 3,462,696,320.33 |
经营活动现金流入的平衡项目 | 0 | 0 | 0 | 0 |
经营活动现金流入小计 | 563,267,466,872.15 | 373,061,403,377.72 | 170,796,465,864.08 | 685,070,474,129.65 |
购买商品、接受劳务支付的现金 | 546,314,360,560.9 | 363,975,978,177.57 | 175,900,550,835.49 | 667,053,925,997.66 |
支付给职工以及为职工支付的现金 | 4,374,165,107.44 | 3,260,728,689.7 | 2,157,554,131.09 | 5,894,676,767.9 |
支付的各项税费 | 3,276,260,977.38 | 2,499,014,181.56 | 1,160,372,329.49 | 5,201,025,303.22 |
支付其他与经营活动有关的现金 | 10,579,711,675.29 | 9,588,767,876.66 | 5,606,962,063.83 | 6,517,410,137.17 |
经营活动现金流出的平衡项目 | 0 | 0 | 0 | 0 |
经营活动现金流出小计 | 564,544,498,321.01 | 379,324,488,925.49 | 184,825,439,359.9 | 684,667,038,205.95 |
经营活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
经营活动产生的现金流量净额 | -1,277,031,448.86 | -6,263,085,547.77 | -14,028,973,495.82 | 403,435,923.7 |
二、投资活动产生的现金流量: | ||||
收回投资收到的现金 | 15,261,149,166.64 | 9,446,877,664.72 | 3,869,969,368.63 | 13,228,957,064.05 |
取得投资收益收到的现金 | 719,270,078.41 | 377,761,304.93 | 191,136,090.45 | 1,500,708,151.58 |
处置固定资产、无形资产和其他长期资产收回的现金净额 | 409,552,380.7 | 158,843,331.75 | 101,003,611.94 | 523,971,597.17 |
处置子公司及其他营业单位收到的现金净额 | 17,470,652.72 | 14,235,517.46 | - | - |
收到的其他与投资活动有关的现金 | 2,556,502,472.83 | 541,470,199.38 | 909,707,311.93 | 242,391,691.46 |
投资活动现金流入的平衡项目 | 0 | 0 | 0 | 0 |
投资活动现金流入小计 | 18,963,944,751.3 | 10,539,188,018.24 | 5,071,816,382.95 | 15,496,028,504.26 |
购建固定资产、无形资产和其他长期资产支付的现金 | 1,622,193,603.76 | 1,096,273,804.89 | 405,306,652.89 | 2,534,106,978.1 |
投资支付的现金 | 16,149,549,190.56 | 10,637,945,455.62 | 4,604,078,706.68 | 20,104,382,633.08 |
取得子公司及其他营业单位支付的现金 | 262,118,142.89 | 13,737,000 | 427,842,194.57 | 2,137,710,851.26 |
支付其他与投资活动有关的现金 | 3,721,752,154.45 | 622,528,734.69 | 761,004,660.18 | 741,047,829.28 |
投资活动现金流出的平衡项目 | 0 | 0 | 0 | 0 |
投资活动现金流出小计 | 21,755,613,091.66 | 12,370,484,995.2 | 6,198,232,214.32 | 25,517,248,291.72 |
投资活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
投资活动产生的现金流量净额 | -2,791,668,340.36 | -1,831,296,976.96 | -1,126,415,831.37 | -10,021,219,787.46 |
三、筹资活动产生的现金流量: | ||||
吸收投资收到的现金 | 2,206,660,000 | 128,360,000 | 155,565,940 | 737,471,589.89 |
其中:子公司吸收少数股东投资收到的现金 | 207,860,000 | 128,360,000 | 155,565,940 | 737,461,589.89 |
取得借款收到的现金 | 148,898,040,175.39 | 106,463,512,079.48 | 62,800,470,624 | 181,023,665,553.26 |
收到其他与筹资活动有关的现金 | 2,811,147,944.62 | 36,801,900 | 1,405,348,125.76 | 638,678,593.85 |
筹资活动现金流入平衡项目 | 0 | 0 | 0 | 0 |
筹资活动现金流入小计 | 153,915,848,120.01 | 106,628,673,979.48 | 64,361,384,689.76 | 182,399,815,737 |
偿还债务支付的现金 | 138,483,981,890.57 | 92,823,724,060.66 | 46,191,058,764.13 | 167,353,225,181.7 |
分配股利、利润或偿付利息支付的现金 | 3,469,649,014.33 | 1,609,433,242.57 | 599,075,135.23 | 3,485,999,501.91 |
其中:子公司支付给少数股东的股利、利润 | 850,943,641.26 | 501,880,872.95 | - | 633,980,987.15 |
支付其他与筹资活动有关的现金 | 5,249,105,343.78 | 797,714,723.38 | 2,065,831,334.62 | 1,719,030,108.09 |
筹资活动现金流出平衡项目 | 0 | 0 | 0 | 0 |
筹资活动现金流出小计 | 147,202,736,248.68 | 95,230,872,026.61 | 48,855,965,233.98 | 172,558,254,791.7 |
筹资活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
筹资活动产生的现金流量净额 | 6,713,111,871.33 | 11,397,801,952.87 | 15,505,419,455.78 | 9,841,560,945.3 |
四、汇率变动对现金及现金等价物的影响 | -115,822,006.02 | -60,099,981.97 | -42,973,663.32 | -9,620,547.17 |
现金及现金等价物净增加额平衡项目 | 0 | 0 | 0 | 0 |
五、现金及现金等价物净增加额 | 2,528,590,076.09 | 3,243,319,446.17 | 307,056,465.27 | 214,156,534.37 |
加:期初现金及现金等价物余额 | 10,851,601,538.41 | 10,851,601,538.41 | 10,851,601,538.41 | 10,637,445,004.04 |
期末现金及现金等价物余额平衡项目 | 0 | 0 | 0 | 0 |
期末现金及现金等价物余额 | 13,380,191,614.5 | 14,094,920,984.58 | 11,158,658,003.68 | 10,851,601,538.41 |
补充资料: | ||||
净利润 | - | 2,515,974,248.52 | - | 5,699,659,922.69 |
资产减值准备 | - | 969,570,271.71 | - | 1,201,402,427.9 |
固定资产和投资性房地产折旧 | - | 720,835,306 | - | 1,470,383,377.23 |
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧 | - | 720,835,306 | - | 1,470,383,377.23 |
无形资产摊销 | - | 132,340,509.36 | - | 274,135,325.46 |
长期待摊费用摊销 | - | 78,918,925.55 | - | 149,744,384.87 |
处置固定资产、无形资产和其他长期资产的损失 | - | -155,547,927.66 | - | -453,647,017.9 |
固定资产报废损失 | - | 789,968.96 | - | 3,558,403.19 |
公允价值变动损失 | - | -395,620,984.08 | - | -929,958.14 |
财务费用 | - | 969,395,037.21 | - | 1,364,868,328.58 |
投资损失 | - | -783,902,487.71 | - | -1,389,141,996.59 |
递延所得税 | - | 1,408,899.18 | - | -83,646,209.08 |
其中:递延所得税资产减少 | - | -58,133,343.73 | - | -239,582,983.66 |
递延所得税负债增加 | - | 59,542,242.91 | - | 155,936,774.58 |
存货的减少 | - | -17,810,754,493.3 | - | -2,999,564,459.5 |
经营性应收项目的减少 | - | -22,599,324,128.52 | - | -5,165,559,731.46 |
经营性应付项目的增加 | - | 29,974,448,766.99 | - | -98,120,528.83 |
不涉及现金收支的投资和筹资活动金额其他项目 | - | - | - | 150,501,875.16 |
现金的期末余额 | - | 14,094,920,984.58 | - | 10,851,601,538.41 |
减:现金的期初余额 | - | 10,851,601,538.41 | - | 10,637,445,004.04 |
公告日期 | 2024-10-29 | 2024-08-27 | 2024-04-27 | 2024-04-27 |
审计意见(境内) | 标准无保留意见 |